FDA expected to authorize Pfizer booster for all adults amid rising COVID cases

The Food and Drug Administration is expected to authorize a Pfizer COVID-19 vaccine booster for all adults as early as Thursday as new cases are rising again around the country.

Email Not Displaying? Click Here